Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S D Hall

Showing results (91-100 of 97) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 97 results.
Neuroscience|September 28, 2014
GABA-mediated changes in inter-hemispheric beta frequency activity in early-stage Parkinson's diseaseS D Hall, E J Prokic, C J McAllister, et al.
Clinical Pharmacology and Therapeutics|April 20, 2007
Cytochrome P450 3A5 genotype is associated with verapamil response in healthy subjectsY Jin, Y-H Wang, J Miao, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 4, 1999
Molecular and physical mechanisms of first-pass extractionS D Hall, K E Thummel, P B Watkins, et al.
Nature Genetics|March 30, 2001
Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expressionP Kuehl, J Zhang, Y Lin, et al.
Pharmacogenetics|October 23, 2001
The human pregnane X receptor: genomic structure and identification and functional characterization of natural allelic variantsJ Zhang, P Kuehl, E D Green, et al.
Clinical Pharmacology and Therapeutics|September 20, 2013
Evaluation of various static in vitro-in vivo extrapolation models for risk assessment of the CYP3A inhibition potential of an investigational drugMd L T Vieira, B Kirby, I Ragueneau-Majlessi, et al.
Pharmacological Reviews|June 1, 2004
PharmGKB update: II. CYP3A5, cytochrome P450, family 3, subfamily A, polypeptide 5E G Schuetz, M V Relling, S Kishi, et al.
Pageof 10

Showing results (91-100 of 97) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 97 results.
Neuroscience|September 28, 2014
GABA-mediated changes in inter-hemispheric beta frequency activity in early-stage Parkinson's diseaseS D Hall, E J Prokic, C J McAllister, et al.
Clinical Pharmacology and Therapeutics|April 20, 2007
Cytochrome P450 3A5 genotype is associated with verapamil response in healthy subjectsY Jin, Y-H Wang, J Miao, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 4, 1999
Molecular and physical mechanisms of first-pass extractionS D Hall, K E Thummel, P B Watkins, et al.
Nature Genetics|March 30, 2001
Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expressionP Kuehl, J Zhang, Y Lin, et al.
Pharmacogenetics|October 23, 2001
The human pregnane X receptor: genomic structure and identification and functional characterization of natural allelic variantsJ Zhang, P Kuehl, E D Green, et al.
Clinical Pharmacology and Therapeutics|September 20, 2013
Evaluation of various static in vitro-in vivo extrapolation models for risk assessment of the CYP3A inhibition potential of an investigational drugMd L T Vieira, B Kirby, I Ragueneau-Majlessi, et al.
Pharmacological Reviews|June 1, 2004
PharmGKB update: II. CYP3A5, cytochrome P450, family 3, subfamily A, polypeptide 5E G Schuetz, M V Relling, S Kishi, et al.
Pageof 10